ClinicalTrials.gg
RecruitingNCT06372054Updated Apr 17, 2024

TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models

An observational study in Oxidative Injury, Stress Physiological and Discogenic Pain, sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Recruiting at 1 site in Italy. Open to participants aged 26 Years to 38 Years. Per ClinicalTrials.gov, last updated 2024-04-17.

Sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
26 Years to 38 Years
Sex
All
01

Study summary

The goal of this observational study is to define a personalized risk model in the super healthy and homogeneous population of Italian Air Force high-performance pilots. This peculiar cohort conducts dynamic activities in an extreme environment, compared to a population of military people not involved in flight activity. The study integrates the analyses of biological samples (urine, blood, and saliva), clinical records, and occupational data collected at different time points and analyzed by omic-based approaches supported by Artificial Intelligence. Data resulting from the study will clarify many etiopathological mechanisms of diseases, allowing the creation of a model of analyses that can be extended to the civilian population and patient cohorts for the potentiation of precision and preventive medicine.

Read the detailed description

The high-performance pilots of the Italian Air Force are "super healthy" individuals subjected to particular working conditions, as changes in temperature, pressure, gravity, acceleration, exposure to cosmic rays and radiation, which determine psycho-physical adaptation mechanisms to maintain homeostasis. However, this environmental exposure may potentially affect human health, well-being and performance.

The study aims to collect exposure data, clinical, physiological data through biosensors and molecular parameters (at different time point), to be integrated by an Artificial Intelligence algorithm expressly trained to create reliable risk models.

The final outcome will consist of the identification of significant biomarkers of pathological risk, in order to better understand the etiopathological mechanisms of many human diseases and apply early and personalized countermeasures to maintain and empower workers' health status and performance, avoiding clinical symptom presentation.

02

Conditions studied

  • Oxidative Injury
  • Stress Physiological
  • Discogenic Pain
  • Cardiovascular Risk Factor
  • Space Maintenance
  • Epigenetic Changes
  • LONGEVITY 1
  • Neuroplasticity
  • NGS

Keywords

  • pilots
  • air force
  • epigenetic change
  • environmental exposure
03

In context

Lead sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is the lead sponsor of 232 studies on the registry; 83 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
26 Years to 38 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of high-performance Italian Air Force pilots, compared to Italian Air Force ground staff.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being part of the Italian Air Force, as in active flight service or ground staff
  • Age between 26 and 38 years
  • Consent to collect biological samples and use the wearable device to monitor exposure parameters

Exclusion criteria

Exclusion Criteria:

  • Age \< 25 years and > 39 years
  • no signature on informed consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes
Biospecimen retention
Samples with dna

Groups and cohorts

  • High-performance Italian Air Force Pilots

    The primary study cohort is represented by "super-healthy" high-performance Italian Air Force Pilots, aged between 26 and 38 years, in active flight service. Intervention: not applicable

    Other: Biological sample collection

  • Italian Air Force ground staff

    This cohort of Italian Air Force ground personnel will be used as a control group to compare data from the pilot cohort.

    Other: Biological sample collection

Interventions

  • OtherBiological sample collection

    Collection of biological samples (blood, urine, saliva) and clinical data

06

What researchers measure

Primary outcomes

  1. Assessment of flight-related exposure data and molecular modifications

    Collection of information on: i) lifestyle, ii) medical examination, iii) previous trauma, iv) cumulative professional exposure to flying, determination of panel of genes and circulating markers to assess prognostic and predictive factors

    Time frame: Through study completion, an average of 3 year

Secondary outcomes

  1. Assessment of General Health

    Recording of general health condition and work stress by General Health Questionnaire by the Effort-Reward Imbalance Questionnaire (ERI)

    Time frame: Through study completion, an average of 3 year

  2. Assessment of Sleep Quality

    Recording of sleep quality by the Sleeping Quality Questionnaire (SQQ)

    Time frame: Through study completion, an average of 3 year

  3. Assessment of eating habits

    Recording of eating habits by Food Frequency Questionnaire (EPIC)

    Time frame: Through study completion, an average of 3 year

  4. Creation of reliable AI and disease-based models for personalized medicine

    Integration of information obtained from anamnesis, questionnaires, biochemical, genomic, epigenomic, proteomic data with the measurement of heart rate, oxygenation, acceleration, external temperature, presence of ultrasound, infrasound and radiation with artificial intelligence algorithm for the creation of reliable models of disease based on personalized medicine

    Time frame: Through study completion, an average of 3 year

07

Study locations

1 of 1 sites recruiting
  • CeMATA - Joint Center for Aerospace Medicine and Advanced Therapy
    Milan, 20139, Italy
    • Stefania E Navone, PhD · Contact · stefania.navone@policlinico.mi.it · 0256660100
    • Giovanni Marfia, MD, PhD · Principal investigator
    • Laura Guarnaccia, PhD · Sub investigator
    • Stefania E Navone, PhD · Sub investigator
    • Monica R Miozzo, PhD · Sub investigator
    • Orazio Granato, PhD · Sub investigator
    • Silvana Pileggi, PhD · Sub investigator
    • Luisella Vigna, MD, PhD · Sub investigator
    • Matteo Bonzini, MD, PhD · Sub investigator
    • Laura Fontana, PhD · Sub investigator
    • Laura Begani, MSc · Sub investigator
    Recruiting
08

References and documents

Publications

  • Marfia G, Navone SE, Guarnaccia L, Campanella R, Locatelli M, Miozzo M, Perelli P, Della Morte G, Catamo L, Tondo P, Campanella C, Lucertini M, Ciniglio Appiani G, Landolfi A, Garzia E. Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro-oncology. J Neurosci Res. 2022 Sep;100(9):1649-1663. doi: 10.1002/jnr.25066. Epub 2022 Jun 9. PubMed 35678198 ↗
  • Marfia G, Guarnaccia L, Navone SE, Ampollini A, Balsamo M, Benelli F, Gaudino C, Garzia E, Fratocchi C, Di Murro C, Ligarotti GK, Campanella C, Landolfi A, Perelli P, Locatelli M, Ciniglio Appiani G. Microgravity and the intervertebral disc: The impact of space conditions on the biomechanics of the spine. Front Physiol. 2023 Mar 14;14:1124991. doi: 10.3389/fphys.2023.1124991. eCollection 2023. PubMed 36998982 ↗

Individual participant data

Plan to share: No — Subject's data will be collected in completely anonymized form.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06372054
Collaborators
University of Milan, Italian Air Force, A-Tono, Ministry of Defense, Italy
Responsible party
Sponsor
First posted
Apr 17, 2024
Start date
Feb 5, 2024
Primary completion
Feb 5, 2025 (estimated)
Completion
Feb 5, 2027 (estimated)
Last update
Apr 17, 2024

Study contacts

Giovanni Marfia, MD, PhD
Contact
giovanni.marfia@policlinico.mi.it
0256660100 ext. +39
Laura Guarnaccia, PhD
Contact
laura.guarnaccia@policlinico.mi.it
0255034268 ext. +39
Giovanni Marfia, MD, PhD
principal investigator · Fondazione IRCCs Ca' Granda Ospedale MAggiore Policlinico, Italian Air Force
Emanuele Garzia, MD, PhD
study chair · Italian Air Force
Marco Locatelli, MD, PhD
study chair · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Francesco Vestito, PhD
study chair · Italian Air Force

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion